- STAT+: OpenEvidence backs study that finds it beats LLMsIn this edition of STAT Health Tech: Dueling research pitting OpenEvidence against general purpose LLMs, use of Dexcom's CGM in children, and more.STAT · 19d ago↗ source
- HHS plan to speed drug research won’t remove ‘self-inflicted’ delaysU.S. clinical trials continue to lose ground to China, but is Operation Trialblazer enough to help America catch up?BioPharma Dive · 19d ago↗ source
- AstraZeneca, Ionis drug fails big heart disease study in major setbackEplontersen’s failure in transthyretin-mediated amyloidosis cardiomyopathy caught Wall Street analysts by surprise and boosted the outlook of rival drugs from Alnylam and BridgeBio Pharma.BioPharma Dive · 19d ago↗ source